theophylline has been researched along with Stroke in 13 studies
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV), and relative mean transit time (rMTT) in the infarct core, penumbra, and unaffected tissue were measured using multi-parametric MRI at baseline and 3‑h follow-up in patients treated with theophylline or placebo as an add-on to thrombolytic therapy." | 9.51 | Perfusion Changes in Acute Stroke Treated with Theophylline as an Add-on to Thrombolysis : A Randomized Clinical Trial Subgroup Analysis. ( Andersen, G; Fiehler, J; Forkert, ND; Hjort, N; Modrau, B; Nygård Johansen, M; Vorum, H; Winder, A, 2022) |
| "We assessed the effect of single-dose theophylline on intracortical and interhemispheric inhibition in patients with chronic stroke, in a double-blind, placebo-controlled, cross-over study." | 9.22 | The neurophysiological effects of single-dose theophylline in patients with chronic stroke: A double-blind, placebo-controlled, randomized cross-over study. ( Boehme, AK; Lazar, RM; Marshall, RS; Martinez-Hernandez, IE; Schambra, HM; Slane, KJ, 2016) |
| "The objective of this review was to assess the effect of theophylline and its analogues, aminophylline and caffeine, in people with confirmed or presumed acute ischaemic stroke." | 8.82 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, PM, 2004) |
| "The objective of this review was to assess the effect of theophylline and its analogues (aminophylline and caffeine) in people with confirmed or presumed acute ischaemic stroke." | 8.80 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, FJ; Bath, PM; Mohiuddin, AA, 2000) |
| "The TEA-Stroke trial (The Theophylline in Acute Ischemic Stroke) was an investigator-initiated 2-center, proof-of-concept, phase II clinical study with a randomized, double-blinded, placebo-controlled design." | 7.96 | Theophylline as an Add-On to Thrombolytic Therapy in Acute Ischemic Stroke: A Randomized Placebo-Controlled Trial. ( Andersen, G; Bach, FW; Eskildsen, HW; Hansen, MB; Hjort, N; Johansen, MB; Mikkelsen, IK; Modrau, B; Mouridsen, K; Nielsen, A; Povlsen, JP; Yavarian, Y; Østergaard, L, 2020) |
| "The relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV), and relative mean transit time (rMTT) in the infarct core, penumbra, and unaffected tissue were measured using multi-parametric MRI at baseline and 3‑h follow-up in patients treated with theophylline or placebo as an add-on to thrombolytic therapy." | 5.51 | Perfusion Changes in Acute Stroke Treated with Theophylline as an Add-on to Thrombolysis : A Randomized Clinical Trial Subgroup Analysis. ( Andersen, G; Fiehler, J; Forkert, ND; Hjort, N; Modrau, B; Nygård Johansen, M; Vorum, H; Winder, A, 2022) |
| "We assessed the effect of single-dose theophylline on intracortical and interhemispheric inhibition in patients with chronic stroke, in a double-blind, placebo-controlled, cross-over study." | 5.22 | The neurophysiological effects of single-dose theophylline in patients with chronic stroke: A double-blind, placebo-controlled, randomized cross-over study. ( Boehme, AK; Lazar, RM; Marshall, RS; Martinez-Hernandez, IE; Schambra, HM; Slane, KJ, 2016) |
| "The objective of this review was to assess the effect of theophylline and its analogues, aminophylline and caffeine, in people with confirmed or presumed acute ischaemic stroke." | 4.82 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, PM, 2004) |
| "The objective of this review was to assess the effect of theophylline and its analogues (aminophylline and caffeine) in people with confirmed or presumed acute ischaemic stroke." | 4.80 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, FJ; Bath, PM; Mohiuddin, AA, 2000) |
| "The TEA-Stroke trial (The Theophylline in Acute Ischemic Stroke) was an investigator-initiated 2-center, proof-of-concept, phase II clinical study with a randomized, double-blinded, placebo-controlled design." | 3.96 | Theophylline as an Add-On to Thrombolytic Therapy in Acute Ischemic Stroke: A Randomized Placebo-Controlled Trial. ( Andersen, G; Bach, FW; Eskildsen, HW; Hansen, MB; Hjort, N; Johansen, MB; Mikkelsen, IK; Modrau, B; Mouridsen, K; Nielsen, A; Povlsen, JP; Yavarian, Y; Østergaard, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Modrau, B | 2 |
| Andersen, G | 2 |
| Mikkelsen, IK | 1 |
| Nielsen, A | 1 |
| Hansen, MB | 1 |
| Johansen, MB | 1 |
| Eskildsen, HW | 1 |
| Povlsen, JP | 1 |
| Yavarian, Y | 1 |
| Mouridsen, K | 1 |
| Østergaard, L | 1 |
| Bach, FW | 1 |
| Hjort, N | 2 |
| Winder, A | 1 |
| Nygård Johansen, M | 1 |
| Fiehler, J | 1 |
| Vorum, H | 1 |
| Forkert, ND | 1 |
| Schambra, HM | 1 |
| Martinez-Hernandez, IE | 1 |
| Slane, KJ | 1 |
| Boehme, AK | 1 |
| Marshall, RS | 1 |
| Lazar, RM | 1 |
| SACINO, G | 1 |
| ERLEY, E | 1 |
| EICHHORN, O | 1 |
| SLADKI, E | 1 |
| PRUSINSKI, A | 1 |
| DORNAUS, W | 1 |
| PUFFER, E | 1 |
| FREUNDT, KJ | 1 |
| FRUHMANN, H | 1 |
| MUELLER, WK | 1 |
| Bath, PM | 2 |
| Mohiuddin, AA | 1 |
| Bath, FJ | 1 |
2 reviews available for theophylline and Stroke
| Article | Year |
|---|---|
Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke.
Topics: Aminophylline; Brain Ischemia; Caffeine; Humans; Randomized Controlled Trials as Topic; Stroke; Theo | 2004 |
Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke.
Topics: Aminophylline; Brain Ischemia; Caffeine; Humans; Stroke; Theophylline; Vasodilator Agents | 2000 |
2 trials available for theophylline and Stroke
| Article | Year |
|---|---|
Perfusion Changes in Acute Stroke Treated with Theophylline as an Add-on to Thrombolysis : A Randomized Clinical Trial Subgroup Analysis.
Topics: Animals; Brain Ischemia; Cerebrovascular Circulation; Humans; Infarction; Magnetic Resonance Imaging | 2022 |
The neurophysiological effects of single-dose theophylline in patients with chronic stroke: A double-blind, placebo-controlled, randomized cross-over study.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Chronic Disease; Cross-Over Studies; Double-Blind Me | 2016 |
9 other studies available for theophylline and Stroke
| Article | Year |
|---|---|
Theophylline as an Add-On to Thrombolytic Therapy in Acute Ischemic Stroke: A Randomized Placebo-Controlled Trial.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Ischemia; Male; Middle | 2020 |
[Effect of combined theophylline-ethylenediamine, rutin and ascorbic acid in therapy of cerebral apoplexy; early clinico-therapeutic results].
Topics: Aminophylline; Ascorbic Acid; Cerebral Hemorrhage; Ethylenediamines; Flavonoids; Humans; Rutin; Stro | 1955 |
[Experience in the treatment of cerebral apoplexy].
Topics: Cerebral Hemorrhage; Humans; Stroke; Theophylline | 1956 |
[Treatment of stroke with peripherin-Homburg].
Topics: Cerebral Hemorrhage; Humans; Intermediate Filaments; Peripherins; Stroke; Theophylline | 1957 |
[Treatment of apoplexy with a theophylline derivative & ephedrine in the light of recent pathogenetic theories].
Topics: Cerebral Hemorrhage; Ephedrine; Humans; Light; Stroke; Theophylline | 1959 |
[On the therapy of apoplexy].
Topics: Aesculus; Cerebral Hemorrhage; Stroke; Theophylline | 1960 |
[Clinical studies on the therapy of apoplexy].
Topics: Aesculus; Biomedical Research; Fagaceae; Stroke; Theophylline | 1960 |
[ON THE TREATMENT OF APOPLEXY WITH COMPLAMIN (7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE].
Topics: Cerebrovascular Disorders; Geriatrics; Humans; Niacin; Nicotinic Acids; Stroke; Theophylline; Xanthi | 1963 |
[On the treatment of "apoplectic attacks" with apoplectal].
Topics: Aesculus; Fagaceae; Seizures; Stroke; Theophylline | 1960 |